Daiwa Securities Group Inc. - G1 THERAPEUTICS INC ownership

G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 100 filers reported holding G1 THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 17.12 and the average weighting 0.2%.

Quarter-by-quarter ownership
Daiwa Securities Group Inc. ownership history of G1 THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$01450.0%0.00%
Q2 2023$01450.0%0.00%
Q1 2023$0
-100.0%
1450.0%0.00%
Q4 2022$1
-100.0%
1450.0%0.00%
Q3 2022$2,000
+100.0%
1450.0%0.00%
Q2 2022$1,0000.0%1450.0%0.00%
Q1 2022$1,0000.0%1450.0%0.00%
Q4 2021$1,000
-50.0%
1450.0%0.00%
Q3 2021$2,0000.0%145
+101.4%
0.00%
Q2 2021$2,0000.0%720.0%0.00%
Q1 2021$2,000
+100.0%
720.0%0.00%
Q4 2020$1,000
-50.0%
72
-66.0%
0.00%
Q3 2020$2,0000.0%2120.0%0.00%
Q2 2020$2,0000.0%2120.0%0.00%
Q1 2020$2,000
-66.7%
2120.0%0.00%
Q4 2019$6,000
+20.0%
212
-10.9%
0.00%
Q3 2019$5,000
-28.6%
2380.0%0.00%
Q2 2019$7,000
+75.0%
2380.0%0.00%
Q1 2019$4,000
+33.3%
238
+51.6%
0.00%
Q4 2018$3,000
-62.5%
1570.0%0.00%
Q3 2018$8,000
+14.3%
1570.0%0.00%
Q2 2018$7,000
+16.7%
1570.0%0.00%
Q1 2018$6,0001570.00%
Other shareholders
G1 THERAPEUTICS INC shareholders Q4 2019
NameSharesValueWeighting ↓
MPM BioImpact LLC 650,000$3,529,5000.92%
CHI Advisors LLC 333,945$1,813,3210.48%
PVG ASSET MANAGEMENT CORP 15,585$84,6260.37%
Rhenman & Partners Asset Management AB 370,000$2,009,1000.21%
NEEDHAM INVESTMENT MANAGEMENT LLC 184,000$999,1200.18%
Birchview Capital, LP 40,000$2170.15%
XTX Topco Ltd 102,282$555,3910.12%
Tekla Capital Management LLC 423,869$2,301,6090.09%
Woodline Partners LP 1,028,967$5,587,2910.08%
Curi Wealth Management, LLC 81,009$439,8790.06%
View complete list of G1 THERAPEUTICS INC shareholders